(Q45222030)

English

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random (English)

1 reference

Europe PubMed Central

11 December 2017

0 references

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

Coenraad Dirk Adriaan Stehouwer

8

object named as

C D A Stehouwer

1 reference

Europe PubMed Central

11 December 2017

Casper G. Schalkwijk

5

object named as

C G Schalkwijk

1 reference

Europe PubMed Central

11 December 2017

author name string

M T Schram

1

1 reference

Europe PubMed Central

11 December 2017

F J van Ittersum

2

1 reference

Europe PubMed Central

11 December 2017

A Spoelstra-de Man

3

1 reference

Europe PubMed Central

11 December 2017

R A J M van Dijk

4

1 reference

Europe PubMed Central

11 December 2017

R G Ijzerman

6

1 reference

Europe PubMed Central

11 December 2017

J W R Twisk

7

1 reference

Europe PubMed Central

11 December 2017

publication date

1 June 2005

1 reference

Europe PubMed Central

11 December 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

11 December 2017

19

1 reference

Europe PubMed Central

11 December 2017

6

1 reference

Europe PubMed Central

11 December 2017

429-437

1 reference

Europe PubMed Central

11 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001812

0 references

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effect of losartan in aging-related endothelial impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

21 January 2018

Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001812

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.JHH.1001812

1 reference

Europe PubMed Central

11 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45222030&oldid=1561299999"